课题基金 / 基金详情

Mammalian L1 retrotransposons as genetic characters

Mammalian L1 retrotransposons as genetic characters
哺乳动物 L1 逆转录转座子作为遗传特征
批准号:
10700672
负责人:
ANTHONY V. FURANO
金额:
$0.05万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

ANTHONY V. FURANO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The original impetus for this project was that mammalian L1 elements are obligate intra-genomic parasites that replicate by copying their RNA transcripts into genomic DNA. They have been residing and evolving in mammalian lineages for at least the last 100 million years, during which time at least 16 successive L1 families arose, only to go extinct having been supplanted by a novel active family, which is present in modern humans. The DNA inserts of the extinct L1 families remain in the genome where they accumulate mutations at the neutral mutation rate. These insertions represent an unparalleled source of DNA fossils that provide a genetic record of its host and our analysis of which suggested that DNA repair may be mutagenic. We had earlier demonstrated that this is indeed the case and determined several mechanisms of repair-induced mutagenesis. However, as we devoted no resources this project in the current rating year we have nothin new to report.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.dnarep.2015.04.012
发表时间: 2015-08
期刊: DNA repair
影响因子: 3.8
作者: [Chen J, Furano AV]
通讯作者: Furano AV
DOI: 10.7554/elife.02001
发表时间: 2014-04-29
期刊: eLife
影响因子: 7.7
作者: [Chen J, Miller BF, Furano AV]
通讯作者: Furano AV
MAMMALIAN TRANSPOSONS
Mammalian L1 retrotransposon replication
Mammalian L1 retrotransposons as genetic characters
Mammalian L1 retrotransposon replication
国内基金
海外基金
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
  • 批准号:
    JCZRLH202601177
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
  • 批准号:
    2026JJ80500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    阳帆
  • 依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
  • 批准号:
    2026JJ81975
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖娇
  • 依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究